217 related articles for article (PubMed ID: 8973755)
21. Discovery of losartan, the first angiotensin II receptor antagonist.
Timmermans PB; Duncia JV; Carini DJ; Chiu AT; Wong PC; Wexler RR; Smith RD
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
[TBL] [Abstract][Full Text] [Related]
22. Modulation of ANG II receptor and its mRNA in normal rat by low-protein feeding.
Benabe JE; Wang S; Wilcox JN; Martinez-Maldonado M
Am J Physiol; 1993 Nov; 265(5 Pt 2):F660-9. PubMed ID: 8238546
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
Kawano H; Cody RJ; Graf K; Goetze S; Kawano Y; Schnee J; Law RE; Hsueh WA
Hypertension; 2000 Jan; 35(1 Pt 2):273-9. PubMed ID: 10642310
[TBL] [Abstract][Full Text] [Related]
24. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
Cardiovasc Res; 1996 Nov; 32(5):973-9. PubMed ID: 8944829
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
26. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.
Hogarty DC; Speakman EA; Puig V; Phillips MI
Brain Res; 1992 Jul; 586(2):289-94. PubMed ID: 1521162
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats.
Ohnishi K; Murase M; Nakano D; Pelisch N; Hitomi H; Kobori H; Morimoto S; Mori H; Masaki T; Ohmori K; Kohno M; Ichihara A; Nishiyama A
J Pharmacol Sci; 2013; 122(2):103-8. PubMed ID: 23698111
[TBL] [Abstract][Full Text] [Related]
28. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats.
Zou LX; Imig JD; von Thun AM; Hymel A; Ono H; Navar LG
Hypertension; 1996 Oct; 28(4):669-77. PubMed ID: 8843896
[TBL] [Abstract][Full Text] [Related]
29. Losartan blocks aldosterone and renal vascular responses to angiotensin II in humans.
Gandhi SK; Ryder DH; Brown NJ
Hypertension; 1996 Dec; 28(6):961-6. PubMed ID: 8952583
[TBL] [Abstract][Full Text] [Related]
30. Fibrous tissue and angiotensin II.
Sun Y; Ramires FJ; Zhou G; Ganjam VK; Weber KT
J Mol Cell Cardiol; 1997 Aug; 29(8):2001-12. PubMed ID: 9281434
[TBL] [Abstract][Full Text] [Related]
31. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
Foucart S; Patrick SK; Oster L; de Champlain J
Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
[TBL] [Abstract][Full Text] [Related]
32. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II.
Gahnem F; Camargo MJ; von Lutterotti N; Laragh JH; Sealey JE
J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857
[TBL] [Abstract][Full Text] [Related]
33. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures.
Gowrisankar YV; Clark MA
J Neurochem; 2016 Jul; 138(1):74-85. PubMed ID: 27085714
[TBL] [Abstract][Full Text] [Related]
35. Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats.
Ruan X; Arendshorst WJ
Am J Physiol; 1996 Jun; 270(6 Pt 2):F945-52. PubMed ID: 8764313
[TBL] [Abstract][Full Text] [Related]
36. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells.
Chansel D; Bizet T; Vandermeersch S; Pham P; Levy B; Ardaillou R
Am J Physiol; 1994 Mar; 266(3 Pt 2):F384-93. PubMed ID: 8160786
[TBL] [Abstract][Full Text] [Related]
38. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II.
Gorbea-Oppliger VJ; Fink GD
J Pharmacol Exp Ther; 1995 May; 273(2):611-6. PubMed ID: 7752062
[TBL] [Abstract][Full Text] [Related]
39. The advantages of angiotensin II antagonism.
Burnier M; Waeber B; Brunner HR
J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
[TBL] [Abstract][Full Text] [Related]
40. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes In vitro.
Malhotra R; Sadoshima J; Brosius FC; Izumo S
Circ Res; 1999 Jul; 85(2):137-46. PubMed ID: 10417395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]